Bacillus Calmette - Guerin ( BCG ) for Urothelial Carcinoma of the Bladder

Timothy P. Kresowik, Thomas S. Griffith

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations
Original languageEnglish (US)
Title of host publicationEmerging Cancer Therapy
Subtitle of host publicationMicrobial Approaches and Biotechnological Tools
PublisherJohn Wiley and Sons
Number of pages22
ISBN (Print)9780470444672
StatePublished - Aug 18 2010


  • BCG development landmarks-immunotherapeutic agents for bladder cancer
  • Bacillus Calmette-Guerin (BCG) - for urothelial carcinoma of bladder
  • Genetic determinants of BCG response

Cite this